- Home
- BLRX vs IINN Comparison
BLRX vs IINN Comparison
Compare BLRX & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- IINN
- Stock Information
- Founded
- BLRX 2003
- IINN 2018
- Country
- BLRX Israel
- IINN Israel
- Employees
- BLRX N/A
- IINN N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- IINN Medical/Dental Instruments
- Sector
- BLRX Health Care
- IINN Health Care
- Exchange
- BLRX Nasdaq
- IINN Nasdaq
- Market Cap
- BLRX 12.1M
- IINN 13.7M
- IPO Year
- BLRX 2011
- IINN 2021
- Fundamental
- Price
- BLRX $5.25
- IINN $0.61
- Analyst Decision
- BLRX Strong Buy
- IINN
- Analyst Count
- BLRX 2
- IINN 0
- Target Price
- BLRX $19.00
- IINN N/A
- AVG Volume (30 Days)
- BLRX 1.9M
- IINN 788.2K
- Earning Date
- BLRX 05-27-2025
- IINN 06-10-2025
- Dividend Yield
- BLRX N/A
- IINN N/A
- EPS Growth
- BLRX N/A
- IINN N/A
- EPS
- BLRX N/A
- IINN N/A
- Revenue
- BLRX $22,340,000.00
- IINN N/A
- Revenue This Year
- BLRX N/A
- IINN N/A
- Revenue Next Year
- BLRX N/A
- IINN N/A
- P/E Ratio
- BLRX N/A
- IINN N/A
- Revenue Growth
- BLRX 91.68
- IINN N/A
- 52 Week Low
- BLRX $2.30
- IINN $0.40
- 52 Week High
- BLRX $35.60
- IINN $2.39
- Technical
- Relative Strength Index (RSI)
- BLRX 84.90
- IINN 59.34
- Support Level
- BLRX $3.32
- IINN $0.40
- Resistance Level
- BLRX $3.97
- IINN $0.56
- Average True Range (ATR)
- BLRX 0.46
- IINN 0.05
- MACD
- BLRX 0.14
- IINN 0.01
- Stochastic Oscillator
- BLRX 47.06
- IINN 91.27
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.